Physician profile
Danielle Wilhour
NPI 1023438058
$1,656.09
in general payments reported to CMS, 2019-2025
18 companies · $297 in 2025
The $297 reported for 2025 was less than what a typical Pain Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $405).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $699 · 2020: $12.49 · 2022: $256 · 2023: $337 · 2024: $54.67 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $396.52 | 2019-2022 | |
| Abbvie INC. | $315.09 | 2023-2025 | Botox |
| Impel Pharmaceuticals INC. | $275.70 | 2023 | Trudhesa |
| Amgen INC. | $166.73 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $94.73 | 2022 | |
| Axsome Therapeutics, INC. | $81.10 | 2025 | Symbravo |
| Promius Pharma LLC | $74.76 | 2019 | |
| Allergan, INC. | $53.44 | 2019 | |
| Upsher-Smith Laboratories LLC | $46.85 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $30.17 | 2019 | |
| Dr.Reddy'S Laboratories,INC. | $26.64 | 2019 | |
| Avanir Pharmaceuticals, INC. | $19.94 | 2019 | |
| Pfizer INC. | $16.92 | 2023 | |
| Novartis Pharmaceuticals Corporation | $16.31 | 2019 | |
| Lilly USA, LLC | $14.30 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $13.49 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $13.40 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Wilhour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.